AbCellera Biologics Inc.
|
38.02 Million USD
|
99.185%
|
Alkermes plc
|
1.66 Billion USD
|
99.981%
|
Agenus Inc.
|
156.31 Million USD
|
99.802%
|
Aptorum Group Limited
|
431.37 Thousand USD
|
28.137%
|
Ardelyx, Inc.
|
124.45 Million USD
|
99.751%
|
Dyadic International, Inc.
|
2.89 Million USD
|
89.306%
|
Eton Pharmaceuticals, Inc.
|
31.64 Million USD
|
99.02%
|
Lantern Pharma Inc.
|
- USD
|
-Infinity%
|
Inhibikase Therapeutics, Inc.
|
260.5 Thousand USD
|
-19.002%
|
Novavax, Inc.
|
983.7 Million USD
|
99.968%
|
Janux Therapeutics, Inc.
|
8.08 Million USD
|
96.165%
|
Pyxis Oncology, Inc.
|
- USD
|
-Infinity%
|
TransCode Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Ocuphire Pharma, Inc.
|
19.04 Million USD
|
98.373%
|
Outlook Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Madrigal Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
SELLAS Life Sciences Group, Inc.
|
- USD
|
-Infinity%
|
Syros Pharmaceuticals, Inc.
|
9.93 Million USD
|
96.88%
|
Barinthus Biotherapeutics plc
|
802 Thousand USD
|
61.347%
|
Windtree Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Xeris Biopharma Holdings, Inc.
|
163.91 Million USD
|
99.811%
|
Clearside Biomedical, Inc.
|
8.22 Million USD
|
96.231%
|
C4 Therapeutics, Inc.
|
20.75 Million USD
|
98.506%
|
Alnylam Pharmaceuticals, Inc.
|
1.82 Billion USD
|
99.983%
|
AlloVir, Inc.
|
- USD
|
-Infinity%
|
Arrowhead Pharmaceuticals, Inc.
|
240.73 Million USD
|
99.871%
|
VYNE Therapeutics Inc.
|
424 Thousand USD
|
26.887%
|
Bicycle Therapeutics plc
|
26.97 Million USD
|
98.851%
|
BioXcel Therapeutics, Inc.
|
1.38 Million USD
|
77.536%
|
ChromaDex Corporation
|
83.57 Million USD
|
99.629%
|
Chimerix, Inc.
|
324 Thousand USD
|
4.321%
|
Corbus Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
Caribou Biosciences, Inc.
|
34.47 Million USD
|
99.101%
|
CRISPR Therapeutics AG
|
371.2 Million USD
|
99.916%
|
Precision BioSciences, Inc.
|
48.72 Million USD
|
99.364%
|
Fate Therapeutics, Inc.
|
63.53 Million USD
|
99.512%
|
Fortress Biotech, Inc.
|
84.51 Million USD
|
99.633%
|
Fortress Biotech, Inc.
|
84.51 Million USD
|
99.633%
|
HOOKIPA Pharma Inc.
|
20.12 Million USD
|
98.46%
|
ImmuCell Corporation
|
17.47 Million USD
|
98.226%
|
IDEAYA Biosciences, Inc.
|
23.38 Million USD
|
98.674%
|
Immix Biopharma, Inc.
|
- USD
|
-Infinity%
|
Incyte Corporation
|
3.69 Billion USD
|
99.992%
|
Innoviva, Inc.
|
310.46 Million USD
|
99.9%
|
IO Biotech, Inc.
|
- USD
|
-Infinity%
|
Jaguar Health, Inc.
|
9.76 Million USD
|
96.824%
|
Keros Therapeutics, Inc.
|
151 Thousand USD
|
-105.298%
|
Ligand Pharmaceuticals Incorporated
|
131.31 Million USD
|
99.764%
|
ContextLogic Inc.
|
287 Million USD
|
99.892%
|
MiMedx Group, Inc.
|
321.47 Million USD
|
99.904%
|
MEI Pharma, Inc.
|
65.29 Million USD
|
99.525%
|
NextCure, Inc.
|
- USD
|
-Infinity%
|
Onconetix, Inc.
|
58.46 Thousand USD
|
-430.232%
|
Oncternal Therapeutics, Inc.
|
785 Thousand USD
|
60.51%
|
Opthea Limited
|
261.85 Thousand USD
|
-18.384%
|
Psyence Biomedical Ltd.
|
- USD
|
-Infinity%
|
Vaxcyte, Inc.
|
- USD
|
-Infinity%
|
PDS Biotechnology Corporation
|
- USD
|
-Infinity%
|
Precigen, Inc.
|
6.22 Million USD
|
95.02%
|
Pharming Group N.V.
|
245.31 Million USD
|
99.874%
|
Phathom Pharmaceuticals, Inc.
|
682 Thousand USD
|
54.545%
|
Pieris Pharmaceuticals, Inc.
|
42.81 Million USD
|
99.276%
|
PureTech Health plc
|
3.33 Million USD
|
90.691%
|
Rigel Pharmaceuticals, Inc.
|
116.88 Million USD
|
99.735%
|
Avidity Biosciences, Inc.
|
9.56 Million USD
|
96.757%
|
Reviva Pharmaceuticals Holdings, Inc.
|
- USD
|
-Infinity%
|
Sangamo Therapeutics, Inc.
|
176.23 Million USD
|
99.824%
|
Sol-Gel Technologies Ltd.
|
1.55 Million USD
|
80.051%
|
Acelyrin, Inc.
|
- USD
|
-Infinity%
|
Salarius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Summit Therapeutics Inc.
|
- USD
|
-Infinity%
|
Sensei Biotherapeutics, Inc.
|
- USD
|
-Infinity%
|
Senti Biosciences, Inc.
|
2.56 Million USD
|
87.895%
|
Stoke Therapeutics, Inc.
|
8.78 Million USD
|
96.469%
|
Elevation Oncology, Inc.
|
- USD
|
-Infinity%
|
Alaunos Therapeutics, Inc.
|
5000.00 USD
|
-6100.0%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
- USD
|
-Infinity%
|
Entrada Therapeutics, Inc.
|
129.01 Million USD
|
99.76%
|
VistaGen Therapeutics, Inc.
|
1.06 Million USD
|
70.865%
|
Kintara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Wave Life Sciences Ltd.
|
113.3 Million USD
|
99.726%
|
Seer, Inc.
|
15.18 Million USD
|
97.958%
|
Verrica Pharmaceuticals Inc.
|
5.12 Million USD
|
93.95%
|
Aadi Bioscience, Inc.
|
24.35 Million USD
|
98.727%
|
ESSA Pharma Inc.
|
- USD
|
-Infinity%
|
GlycoMimetics, Inc.
|
10 Thousand USD
|
-3000.0%
|
GT Biopharma, Inc.
|
- USD
|
-Infinity%
|
Inhibrx Biosciences, Inc.
|
1.8 Million USD
|
82.778%
|
Akebia Therapeutics, Inc.
|
194.62 Million USD
|
99.841%
|
Catalyst Pharmaceuticals, Inc.
|
398.2 Million USD
|
99.922%
|
Longboard Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Orchestra BioMed Holdings, Inc.
|
2.76 Million USD
|
88.768%
|
Alzamend Neuro, Inc.
|
- USD
|
-Infinity%
|
Sorrento Therapeutics, Inc.
|
62.83 Million USD
|
99.507%
|
TRACON Pharmaceuticals, Inc.
|
12.04 Million USD
|
97.426%
|
Viracta Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Rocket Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Aptose Biosciences Inc.
|
- USD
|
-Infinity%
|
ZyVersa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Soligenix, Inc.
|
839.35 Thousand USD
|
63.067%
|
Century Therapeutics, Inc.
|
2.23 Million USD
|
86.13%
|
Kura Oncology, Inc.
|
- USD
|
-Infinity%
|
TScan Therapeutics, Inc.
|
21.04 Million USD
|
98.527%
|
Intensity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Ocean Biomedical, Inc.
|
- USD
|
-Infinity%
|
CytomX Therapeutics, Inc.
|
101.21 Million USD
|
99.694%
|
Autolus Therapeutics plc
|
1.69 Million USD
|
81.743%
|
Mineralys Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EyePoint Pharmaceuticals, Inc.
|
46.01 Million USD
|
99.326%
|
Eterna Therapeutics Inc.
|
68 Thousand USD
|
-355.882%
|
Adaptive Biotechnologies Corporation
|
170.27 Million USD
|
99.818%
|
GRI Bio, Inc.
|
21.76 Million USD
|
98.576%
|
Xenetic Biosciences, Inc.
|
2.53 Million USD
|
87.795%
|
Tenaya Therapeutics, Inc.
|
- USD
|
-Infinity%
|
IGM Biosciences, Inc.
|
2.13 Million USD
|
85.446%
|
INmune Bio, Inc.
|
155 Thousand USD
|
-100.0%
|
Heron Therapeutics, Inc.
|
127.04 Million USD
|
99.756%
|
SAB Biotherapeutics, Inc.
|
2.23 Million USD
|
86.154%
|
Pasithea Therapeutics Corp.
|
- USD
|
-Infinity%
|
Entero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Milestone Pharmaceuticals Inc.
|
1 Million USD
|
69.0%
|
X4 Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Atara Biotherapeutics, Inc.
|
8.57 Million USD
|
96.384%
|
Coherus BioSciences, Inc.
|
257.24 Million USD
|
99.879%
|
Verastem, Inc.
|
- USD
|
-Infinity%
|
Abeona Therapeutics Inc.
|
3.5 Million USD
|
91.143%
|
Pliant Therapeutics, Inc.
|
1.58 Million USD
|
80.38%
|
Tonix Pharmaceuticals Holding Corp.
|
7.76 Million USD
|
96.009%
|
Histogen Inc.
|
3.76 Million USD
|
91.775%
|
Aprea Therapeutics, Inc.
|
583.23 Thousand USD
|
46.848%
|
Surrozen, Inc.
|
- USD
|
-Infinity%
|
Organovo Holdings, Inc.
|
109 Thousand USD
|
-184.404%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Ovid Therapeutics Inc.
|
391.69 Thousand USD
|
20.857%
|
Panbela Therapeutics, Inc.
|
- USD
|
-Infinity%
|
CASI Pharmaceuticals, Inc.
|
33.87 Million USD
|
99.085%
|
Cadrenal Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Centessa Pharmaceuticals plc
|
6.85 Million USD
|
95.476%
|
Hepion Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Arcturus Therapeutics Holdings Inc.
|
157.74 Million USD
|
99.803%
|
BioRestorative Therapies, Inc.
|
145.8 Thousand USD
|
-112.62%
|
Apollomics, Inc.
|
821 Thousand USD
|
62.241%
|
Amarin Corporation plc
|
306.91 Million USD
|
99.899%
|
Mesoblast Limited
|
5.9 Million USD
|
94.748%
|
Turnstone Biologics Corp.
|
19.3 Million USD
|
98.394%
|
Kymera Therapeutics, Inc.
|
78.59 Million USD
|
99.606%
|
Synaptogenix, Inc.
|
- USD
|
-Infinity%
|
Tiziana Life Sciences Ltd
|
- USD
|
-Infinity%
|
Aurinia Pharmaceuticals Inc.
|
175.51 Million USD
|
99.823%
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
Monopar Therapeutics Inc.
|
- USD
|
-Infinity%
|
Exelixis, Inc.
|
1.83 Billion USD
|
99.983%
|
Better Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Nurix Therapeutics, Inc.
|
76.98 Million USD
|
99.597%
|
Apellis Pharmaceuticals, Inc.
|
396.59 Million USD
|
99.922%
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
Dermata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Aridis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Gritstone bio, Inc.
|
1.33 Million USD
|
76.709%
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
TNF Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Avid Bioservices, Inc.
|
139.91 Million USD
|
99.778%
|
Insmed Incorporated
|
305.2 Million USD
|
99.898%
|
Virpax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
MediWound Ltd.
|
18.68 Million USD
|
98.341%
|
OmniAb, Inc.
|
34.16 Million USD
|
99.093%
|
Alector, Inc.
|
97.06 Million USD
|
99.681%
|
Seres Therapeutics, Inc.
|
126.32 Million USD
|
99.755%
|
Checkpoint Therapeutics, Inc.
|
103 Thousand USD
|
-200.971%
|
Zai Lab Limited
|
266.71 Million USD
|
99.884%
|
Revance Therapeutics, Inc.
|
234.04 Million USD
|
99.868%
|
Aura Biosciences, Inc.
|
- USD
|
-Infinity%
|
Lyell Immunopharma, Inc.
|
130 Thousand USD
|
-138.462%
|
Immunic, Inc.
|
- USD
|
-Infinity%
|
Tarsus Pharmaceuticals, Inc.
|
17.44 Million USD
|
98.223%
|
Veracyte, Inc.
|
361.05 Million USD
|
99.914%
|
InMed Pharmaceuticals Inc.
|
4.59 Million USD
|
93.258%
|
FibroGen, Inc.
|
147.75 Million USD
|
99.79%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
Adial Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sonnet BioTherapeutics Holdings, Inc.
|
147.8 Thousand USD
|
-109.736%
|
Jazz Pharmaceuticals plc
|
3.83 Billion USD
|
99.992%
|
Cyclacel Pharmaceuticals, Inc.
|
420 Thousand USD
|
26.19%
|
Amylyx Pharmaceuticals, Inc.
|
380.78 Million USD
|
99.919%
|
TG Therapeutics, Inc.
|
233.66 Million USD
|
99.867%
|
Galecto, Inc.
|
- USD
|
-Infinity%
|
Calithera Biosciences, Inc.
|
- USD
|
-Infinity%
|
Fortrea Holdings Inc.
|
3.1 Billion USD
|
99.99%
|
KalVista Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Aptevo Therapeutics Inc.
|
- USD
|
-Infinity%
|
XBiotech Inc.
|
- USD
|
-Infinity%
|
Jasper Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Lyra Therapeutics, Inc.
|
1.55 Million USD
|
80.103%
|
Foghorn Therapeutics Inc.
|
34.15 Million USD
|
99.092%
|
Y-mAbs Therapeutics, Inc.
|
84.81 Million USD
|
99.635%
|
Theravance Biopharma, Inc.
|
57.42 Million USD
|
99.46%
|
Ultragenyx Pharmaceutical Inc.
|
434.24 Million USD
|
99.929%
|
Metagenomi, Inc. Common Stock
|
44.75 Million USD
|
99.307%
|
Vaxxinity, Inc.
|
- USD
|
-Infinity%
|
BioCryst Pharmaceuticals, Inc.
|
331.41 Million USD
|
99.906%
|
Gain Therapeutics, Inc.
|
55.18 Thousand USD
|
-461.798%
|
Cartesian Therapeutics, Inc.
|
26 Million USD
|
98.808%
|
NexImmune, Inc.
|
- USD
|
-Infinity%
|
Creative Medical Technology Holdings, Inc.
|
9000.00 USD
|
-3344.444%
|
Marker Therapeutics, Inc.
|
3.31 Million USD
|
90.638%
|
Regeneron Pharmaceuticals, Inc.
|
13.11 Billion USD
|
99.998%
|
Chemomab Therapeutics Ltd.
|
- USD
|
-Infinity%
|
Scopus BioPharma Inc.
|
- USD
|
-Infinity%
|
RAPT Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Ainos, Inc.
|
122.11 Thousand USD
|
-153.865%
|
Pluri Inc.
|
326 Thousand USD
|
4.908%
|
Prothena Corporation plc
|
91.37 Million USD
|
99.661%
|
Adaptimmune Therapeutics plc
|
60.28 Million USD
|
99.486%
|
Celularity Inc.
|
22.77 Million USD
|
98.639%
|
Rallybio Corporation
|
- USD
|
-Infinity%
|
Cue Biopharma, Inc.
|
5.49 Million USD
|
94.353%
|
MeiraGTx Holdings plc
|
14.01 Million USD
|
97.788%
|
Omeros Corporation
|
- USD
|
-Infinity%
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
Immunocore Holdings plc
|
249.42 Million USD
|
99.876%
|
Cocrystal Pharma, Inc.
|
- USD
|
-Infinity%
|
Cidara Therapeutics, Inc.
|
63.9 Million USD
|
99.515%
|
Blueprint Medicines Corporation
|
249.38 Million USD
|
99.876%
|
CalciMedica, Inc.
|
- USD
|
-Infinity%
|
Cabaletta Bio, Inc.
|
- USD
|
-Infinity%
|
Marinus Pharmaceuticals, Inc.
|
30.98 Million USD
|
99.0%
|
Scholar Rock Holding Corporation
|
- USD
|
-Infinity%
|
Sana Biotechnology, Inc.
|
- USD
|
-Infinity%
|
Pulmatrix, Inc.
|
7.29 Million USD
|
95.752%
|
Elicio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Vigil Neuroscience, Inc.
|
- USD
|
-Infinity%
|
Intellia Therapeutics, Inc.
|
36.27 Million USD
|
99.145%
|
Adlai Nortye Ltd. American Depositary Shares
|
4.99 Million USD
|
93.795%
|
Cytokinetics, Incorporated
|
7.53 Million USD
|
95.883%
|
Eloxx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Nutriband Inc.
|
2.08 Million USD
|
85.134%
|
Protara Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Vor Biopharma Inc.
|
- USD
|
-Infinity%
|
Roivant Sciences Ltd.
|
124.79 Million USD
|
99.752%
|
Evogene Ltd.
|
5.64 Million USD
|
94.504%
|
ProKidney Corp.
|
- USD
|
-Infinity%
|
Applied Therapeutics, Inc.
|
9.99 Million USD
|
96.898%
|
Hoth Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BridgeBio Pharma, Inc.
|
9.3 Million USD
|
96.668%
|
CorMedix Inc.
|
- USD
|
-Infinity%
|
BioLineRx Ltd.
|
4.8 Million USD
|
93.542%
|
Tango Therapeutics, Inc.
|
36.52 Million USD
|
99.151%
|
Galectin Therapeutics Inc.
|
- USD
|
-Infinity%
|
Atai Life Sciences N.V.
|
314 Thousand USD
|
1.274%
|
Renovaro Biosciences Inc.
|
- USD
|
-Infinity%
|
Aerovate Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Zentalis Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sagimet Biosciences Inc.
|
2 Million USD
|
84.5%
|
MediciNova, Inc.
|
1 Million USD
|
69.0%
|
Praxis Precision Medicines, Inc.
|
2.44 Million USD
|
87.331%
|
Cardio Diagnostics Holdings, Inc.
|
17.06 Thousand USD
|
-1716.584%
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
Axsome Therapeutics, Inc.
|
270.6 Million USD
|
99.885%
|
Biomea Fusion, Inc.
|
- USD
|
-Infinity%
|
PTC Therapeutics, Inc.
|
937.82 Million USD
|
99.967%
|
Mereo BioPharma Group plc
|
10 Million USD
|
96.9%
|
Cullinan Oncology, Inc.
|
- USD
|
-Infinity%
|
Syndax Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Absci Corporation
|
5.71 Million USD
|
94.579%
|
NRx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
4D Molecular Therapeutics, Inc.
|
20.72 Million USD
|
98.504%
|
Dyne Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Kiniksa Pharmaceuticals, Ltd.
|
270.25 Million USD
|
99.885%
|
Ventyx Biosciences, Inc.
|
- USD
|
-Infinity%
|
Allakos Inc.
|
- USD
|
-Infinity%
|
Imunon, Inc.
|
- USD
|
-Infinity%
|
Fulcrum Therapeutics, Inc.
|
2.8 Million USD
|
88.948%
|
Corcept Therapeutics Incorporated
|
482.37 Million USD
|
99.936%
|
BioAtla, Inc.
|
- USD
|
-Infinity%
|
NLS Pharmaceutics AG
|
- USD
|
-Infinity%
|
Bio-Path Holdings, Inc.
|
- USD
|
-Infinity%
|
Allogene Therapeutics, Inc.
|
95 Thousand USD
|
-226.316%
|
Larimar Therapeutics, Inc.
|
- USD
|
-Infinity%
|
XOMA Corporation
|
4.75 Million USD
|
93.485%
|
Kezar Life Sciences, Inc.
|
7 Million USD
|
95.571%
|
Cara Therapeutics, Inc.
|
20.96 Million USD
|
98.522%
|
aTyr Pharma, Inc.
|
353 Thousand USD
|
12.181%
|
Aligos Therapeutics, Inc.
|
15.52 Million USD
|
98.004%
|
Akero Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Viridian Therapeutics, Inc.
|
314 Thousand USD
|
1.274%
|
Eliem Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EyeGate Pharmaceuticals, Inc.
|
12.05 Thousand USD
|
-2470.694%
|
Akari Therapeutics, Plc
|
- USD
|
-Infinity%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Halozyme Therapeutics, Inc.
|
829.25 Million USD
|
99.963%
|
Lexaria Bioscience Corp.
|
226.2 Thousand USD
|
-37.042%
|
UroGen Pharma Ltd.
|
82.71 Million USD
|
99.625%
|
Sutro Biopharma, Inc.
|
153.73 Million USD
|
99.798%
|
ZIVO Bioscience, Inc.
|
27.65 Thousand USD
|
-1021.157%
|
Orgenesis Inc.
|
530 Thousand USD
|
41.509%
|
Entera Bio Ltd.
|
- USD
|
-Infinity%
|
GH Research PLC
|
- USD
|
-Infinity%
|
Lisata Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Reneo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Xencor, Inc.
|
168.33 Million USD
|
99.816%
|
60 Degrees Pharmaceuticals, Inc.
|
253.57 Thousand USD
|
-22.253%
|
Replimune Group, Inc.
|
- USD
|
-Infinity%
|
Coeptis Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Vanda Pharmaceuticals Inc.
|
192.64 Million USD
|
99.839%
|
Lexaria Bioscience Corp.
|
226.2 Thousand USD
|
-37.042%
|
Portage Biotech Inc.
|
- USD
|
-Infinity%
|
Cardio Diagnostics Holdings, Inc.
|
17.06 Thousand USD
|
-1716.584%
|
Olema Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
OncoCyte Corporation
|
1.5 Million USD
|
79.375%
|
Qualigen Therapeutics, Inc.
|
5.2 Million USD
|
94.044%
|
Processa Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Purple Biotech Ltd.
|
- USD
|
-Infinity%
|
CollPlant Biotechnologies Ltd.
|
10.95 Million USD
|
97.171%
|
scPharmaceuticals Inc.
|
13.59 Million USD
|
97.719%
|
ProMIS Neurosciences, Inc.
|
- USD
|
-Infinity%
|
HilleVax, Inc.
|
- USD
|
-Infinity%
|
NeuroSense Therapeutics Ltd.
|
- USD
|
-Infinity%
|
Tharimmune, Inc.
|
- USD
|
-Infinity%
|
Genprex, Inc.
|
- USD
|
-Infinity%
|
Neumora Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Atossa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
XTL Biopharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
Virios Therapeutics, Inc.
|
- USD
|
-Infinity%
|
OKYO Pharma Limited
|
- USD
|
-Infinity%
|
Savara Inc.
|
- USD
|
-Infinity%
|
Curis, Inc.
|
10.02 Million USD
|
96.907%
|
Daré Bioscience, Inc.
|
2.8 Million USD
|
88.96%
|
Carmell Therapeutics Corporation
|
- USD
|
-Infinity%
|
Titan Pharmaceuticals, Inc.
|
184 Thousand USD
|
-68.478%
|
Achieve Life Sciences, Inc.
|
- USD
|
-Infinity%
|
BeiGene, Ltd.
|
2.45 Billion USD
|
99.987%
|
Kiromic BioPharma, Inc.
|
- USD
|
-Infinity%
|
Revolution Medicines, Inc. Warrant
|
11.58 Million USD
|
97.323%
|
Protagonist Therapeutics, Inc.
|
60 Million USD
|
99.483%
|
Erasca, Inc.
|
- USD
|
-Infinity%
|
bluebird bio, Inc.
|
29.49 Million USD
|
98.949%
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BioMarin Pharmaceutical Inc.
|
2.41 Billion USD
|
99.987%
|
DBV Technologies S.A.
|
15.72 Million USD
|
98.029%
|
Protagenic Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Moderna, Inc.
|
6.84 Billion USD
|
99.995%
|
Vincerx Pharma, Inc.
|
- USD
|
-Infinity%
|
Fresh Tracks Therapeutics, Inc.
|
8 Million USD
|
96.128%
|
Molecular Templates, Inc.
|
57.3 Million USD
|
99.459%
|
Acrivon Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Travere Therapeutics, Inc.
|
145.23 Million USD
|
99.787%
|
Monte Rosa Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Spruce Biosciences, Inc.
|
10.08 Million USD
|
96.927%
|
Celldex Therapeutics, Inc.
|
6.88 Million USD
|
95.496%
|
Cogent Biosciences, Inc.
|
- USD
|
-Infinity%
|
MacroGenics, Inc.
|
58.74 Million USD
|
99.472%
|
RenovoRx, Inc.
|
- USD
|
-Infinity%
|
Adicet Bio, Inc.
|
- USD
|
-Infinity%
|
Prime Medicine, Inc.
|
- USD
|
-Infinity%
|
Aditxt, Inc.
|
645.17 Thousand USD
|
51.951%
|
Adagene Inc.
|
18.11 Million USD
|
98.288%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
Quantum-Si incorporated
|
1.08 Million USD
|
71.349%
|
Maravai LifeSciences Holdings, Inc.
|
288.94 Million USD
|
99.893%
|
Acurx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Voyager Therapeutics, Inc.
|
250 Million USD
|
99.876%
|
SciSparc Ltd.
|
2.87 Million USD
|
89.232%
|
Vericel Corporation
|
197.51 Million USD
|
99.843%
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
Minerva Neurosciences, Inc.
|
- USD
|
-Infinity%
|
Generation Bio Co.
|
5.9 Million USD
|
94.749%
|
Astria Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Black Diamond Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Arcutis Biotherapeutics, Inc.
|
59.6 Million USD
|
99.48%
|
Invivyd, Inc.
|
- USD
|
-Infinity%
|
Relay Therapeutics, Inc.
|
25.54 Million USD
|
98.787%
|
Quoin Pharmaceuticals, Ltd.
|
- USD
|
-Infinity%
|
Spero Therapeutics, Inc.
|
96.73 Million USD
|
99.68%
|
Artelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
2seventy bio, Inc.
|
100.38 Million USD
|
99.691%
|
ADMA Biologics, Inc.
|
258.21 Million USD
|
99.88%
|
Clene Inc.
|
654 Thousand USD
|
52.599%
|
Capricor Therapeutics, Inc.
|
25.17 Million USD
|
98.769%
|
Boundless Bio, Inc. Common Stock
|
- USD
|
-Infinity%
|
GeoVax Labs, Inc.
|
- USD
|
-Infinity%
|
Recursion Pharmaceuticals, Inc.
|
44.57 Million USD
|
99.305%
|
Citius Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
50 Million USD
|
99.38%
|
Relmada Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Finch Therapeutics Group, Inc.
|
107 Thousand USD
|
-189.72%
|
ALX Oncology Holdings Inc.
|
- USD
|
-Infinity%
|
Vir Biotechnology, Inc.
|
86.18 Million USD
|
99.64%
|
Evaxion Biotech A/S
|
73.11 Thousand USD
|
-324.007%
|
Ocular Therapeutix, Inc.
|
58.44 Million USD
|
99.47%
|
Verve Therapeutics, Inc.
|
11.75 Million USD
|
97.363%
|
Trevena, Inc.
|
3.12 Million USD
|
90.08%
|
Surrozen, Inc.
|
- USD
|
-Infinity%
|
Tyra Biosciences, Inc.
|
- USD
|
-Infinity%
|
Cingulate Inc.
|
- USD
|
-Infinity%
|
Galmed Pharmaceuticals Ltd.
|
- USD
|
-Infinity%
|
Unity Biotechnology, Inc.
|
- USD
|
-Infinity%
|
Tenax Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Terns Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
ACADIA Pharmaceuticals Inc.
|
726.43 Million USD
|
99.957%
|
Connect Biopharma Holdings Limited
|
- USD
|
-Infinity%
|
Clearmind Medicine Inc.
|
- USD
|
-Infinity%
|
Kronos Bio, Inc.
|
6.28 Million USD
|
95.07%
|
Bolt Biotherapeutics, Inc.
|
7.87 Million USD
|
96.064%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Viking Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Statera Biopharma, Inc.
|
- USD
|
-Infinity%
|
ImmunityBio, Inc.
|
622 Thousand USD
|
50.161%
|
Korro Bio, Inc.
|
- USD
|
-Infinity%
|
Kineta, Inc.
|
5.44 Million USD
|
94.304%
|
BioVie Inc.
|
- USD
|
-Infinity%
|
Codexis, Inc.
|
70.14 Million USD
|
99.558%
|
Celularity Inc.
|
22.77 Million USD
|
98.639%
|
Crinetics Pharmaceuticals, Inc.
|
4.01 Million USD
|
92.275%
|
Celcuity Inc.
|
- USD
|
-Infinity%
|
Virax Biolabs Group Limited
|
156.41 Thousand USD
|
-98.186%
|
Cibus, Inc.
|
1.81 Million USD
|
82.939%
|
Eledon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
eFFECTOR Therapeutics, Inc.
|
- USD
|
-Infinity%
|
IN8bio, Inc.
|
- USD
|
-Infinity%
|
Kodiak Sciences Inc.
|
- USD
|
-Infinity%
|
Annexon, Inc.
|
- USD
|
-Infinity%
|
Adverum Biotechnologies, Inc.
|
3.6 Million USD
|
91.389%
|
Assembly Biosciences, Inc.
|
7.16 Million USD
|
95.672%
|
Avalo Therapeutics, Inc.
|
1.92 Million USD
|
83.888%
|
Ionis Pharmaceuticals, Inc.
|
787.64 Million USD
|
99.961%
|
Eyenovia, Inc.
|
3787.00 USD
|
-8085.899%
|
Puma Biotechnology, Inc.
|
235.63 Million USD
|
99.868%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Xilio Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Arcellx, Inc.
|
110.31 Million USD
|
99.719%
|
Cardiff Oncology, Inc.
|
488 Thousand USD
|
36.475%
|
Enanta Pharmaceuticals, Inc.
|
79.2 Million USD
|
99.609%
|
Regulus Therapeutics Inc.
|
- USD
|
-Infinity%
|
Moolec Science SA
|
905.04 Thousand USD
|
65.748%
|
Acumen Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Geron Corporation
|
237 Thousand USD
|
-30.802%
|
LAVA Therapeutics N.V.
|
6.76 Million USD
|
95.42%
|
Royalty Pharma plc
|
2.35 Billion USD
|
99.987%
|
Atea Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Greenwich LifeSciences, Inc.
|
- USD
|
-Infinity%
|
TFF Pharmaceuticals, Inc.
|
733.87 Thousand USD
|
57.758%
|
Mersana Therapeutics, Inc.
|
36.85 Million USD
|
99.159%
|
Humacyte, Inc.
|
- USD
|
-Infinity%
|
Structure Therapeutics Inc.
|
- USD
|
-Infinity%
|
89bio, Inc.
|
- USD
|
-Infinity%
|
PMV Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Avenue Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Genelux Corporation
|
170 Thousand USD
|
-82.353%
|
Trevi Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Lexicon Pharmaceuticals, Inc.
|
1.2 Million USD
|
74.252%
|
Liquidia Corporation
|
17.48 Million USD
|
98.227%
|
Mustang Bio, Inc.
|
- USD
|
-Infinity%
|
Immunovant, Inc.
|
- USD
|
-Infinity%
|
Quantum-Si incorporated
|
1.08 Million USD
|
71.349%
|
Arbutus Biopharma Corporation
|
18.14 Million USD
|
98.291%
|
DiaMedica Therapeutics Inc.
|
- USD
|
-Infinity%
|
Vera Therapeutics, Inc.
|
1.86 Million USD
|
83.351%
|
Acasti Pharma Inc.
|
- USD
|
-Infinity%
|
MiNK Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Pasithea Therapeutics Corp.
|
- USD
|
-Infinity%
|
Xenon Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Elevai Labs, Inc. Common Stock
|
1.71 Million USD
|
81.899%
|
NeuroBo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Tempest Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Soleno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
PepGen Inc.
|
- USD
|
-Infinity%
|
Moleculin Biotech, Inc.
|
- USD
|
-Infinity%
|
United Therapeutics Corporation
|
2.32 Billion USD
|
99.987%
|
Nuvectis Pharma, Inc.
|
- USD
|
-Infinity%
|
Solid Biosciences Inc.
|
- USD
|
-Infinity%
|
BriaCell Therapeutics Corp.
|
- USD
|
-Infinity%
|
Immuneering Corporation
|
- USD
|
-Infinity%
|
Lixte Biotechnology Holdings, Inc.
|
- USD
|
-Infinity%
|
Silo Pharma, Inc.
|
72.1 Thousand USD
|
-329.946%
|
Belite Bio, Inc
|
- USD
|
-Infinity%
|
XOMA Corporation
|
4.75 Million USD
|
93.485%
|
ARS Pharmaceuticals, Inc.
|
30 Thousand USD
|
-933.333%
|
Bionomics Limited
|
- USD
|
-Infinity%
|
Apogee Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
uniQure N.V.
|
15.84 Million USD
|
98.043%
|
Cassava Sciences, Inc.
|
- USD
|
-Infinity%
|
Estrella Immunopharma, Inc.
|
- USD
|
-Infinity%
|
Poseida Therapeutics, Inc.
|
64.7 Million USD
|
99.521%
|
Forte Biosciences, Inc.
|
- USD
|
-Infinity%
|
Anebulo Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Enlivex Therapeutics Ltd.
|
- USD
|
-Infinity%
|
Conduit Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
SeaStar Medical Holding Corporation
|
- USD
|
-Infinity%
|
FibroBiologics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Altimmune, Inc.
|
426 Thousand USD
|
27.23%
|
Amicus Therapeutics, Inc.
|
399.35 Million USD
|
99.922%
|
Alpha Tau Medical Ltd.
|
- USD
|
-Infinity%
|
Compugen Ltd.
|
33.45 Million USD
|
99.073%
|
Peak Bio, Inc.
|
367.87 Thousand USD
|
15.733%
|
Zevra Therapeutics, Inc.
|
27.46 Million USD
|
98.871%
|
Benitec Biopharma Inc.
|
216 Thousand USD
|
-43.519%
|
Spyre Therapeutics, Inc.
|
886 Thousand USD
|
65.011%
|
NKGen Biotech, Inc. Common Stock
|
- USD
|
-Infinity%
|
Zura Bio Limited
|
- USD
|
-Infinity%
|
PolyPid Ltd.
|
- USD
|
-Infinity%
|
Aileron Therapeutics, Inc.
|
- USD
|
-Infinity%
|
NKGen Biotech, Inc. Warrants
|
- USD
|
-Infinity%
|
Instil Bio, Inc.
|
- USD
|
-Infinity%
|
argenx SE
|
1.22 Billion USD
|
99.975%
|
Immunome, Inc.
|
14.01 Million USD
|
97.789%
|
Compass Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Verona Pharma plc
|
- USD
|
-Infinity%
|
enGene Holdings Inc. Warrants
|
- USD
|
-Infinity%
|
Shattuck Labs, Inc.
|
1.65 Million USD
|
81.291%
|
CervoMed Inc.
|
7.14 Million USD
|
95.661%
|
LENZ Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Plus Therapeutics, Inc.
|
4.91 Million USD
|
93.69%
|
Dianthus Therapeutics, Inc.
|
2.82 Million USD
|
89.03%
|
Moolec Science SA
|
905.04 Thousand USD
|
65.748%
|
Enveric Biosciences, Inc.
|
- USD
|
-Infinity%
|
Inovio Pharmaceuticals, Inc.
|
832.01 Thousand USD
|
62.741%
|
AnaptysBio, Inc.
|
17.15 Million USD
|
98.193%
|
Design Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Leap Therapeutics, Inc.
|
- USD
|
-Infinity%
|
NeurAxis, Inc.
|
2.46 Million USD
|
87.399%
|
Seelos Therapeutics, Inc.
|
2.2 Million USD
|
85.928%
|
Lumos Pharma, Inc.
|
2.05 Million USD
|
84.885%
|
Achilles Therapeutics plc
|
- USD
|
-Infinity%
|
enGene Holdings Inc. Common Stock
|
- USD
|
-Infinity%
|
180 Life Sciences Corp.
|
- USD
|
-Infinity%
|
Opiant Pharmaceuticals, Inc.
|
40.72 Million USD
|
99.239%
|
CERo Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
Nutriband Inc.
|
2.08 Million USD
|
85.134%
|
ORIC Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
CG Oncology, Inc. Common stock
|
204 Thousand USD
|
-51.961%
|
Fractyl Health, Inc. Common Stock
|
120 Thousand USD
|
-158.333%
|
Rani Therapeutics Holdings, Inc.
|
- USD
|
-Infinity%
|
MoonLake Immunotherapeutics
|
- USD
|
-Infinity%
|
Palisade Bio, Inc.
|
250 Thousand USD
|
-24.0%
|
Tourmaline Bio, Inc.
|
- USD
|
-Infinity%
|
Beam Therapeutics Inc.
|
377.7 Million USD
|
99.918%
|
Neurogene Inc.
|
- USD
|
-Infinity%
|
Mirum Pharmaceuticals, Inc.
|
186.37 Million USD
|
99.834%
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
CARGO Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Sesen Bio, Inc.
|
40 Million USD
|
99.225%
|
Enliven Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Kiora Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Iovance Biotherapeutics, Inc.
|
1.18 Million USD
|
73.928%
|
Taysha Gene Therapies, Inc.
|
15.45 Million USD
|
97.994%
|
Athira Pharma, Inc.
|
- USD
|
-Infinity%
|
Vaccinex, Inc.
|
570 Thousand USD
|
45.614%
|
HCW Biologics Inc.
|
2.84 Million USD
|
89.091%
|
XOMA Corporation
|
4.75 Million USD
|
93.485%
|
Nektar Therapeutics
|
90.12 Million USD
|
99.656%
|
Arvinas, Inc.
|
78.5 Million USD
|
99.605%
|
Tevogen Bio Holdings Inc.
|
- USD
|
-Infinity%
|
Merus N.V.
|
43.94 Million USD
|
99.295%
|
Omega Therapeutics, Inc.
|
3.09 Million USD
|
89.981%
|
Quince Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Rezolute, Inc.
|
- USD
|
-Infinity%
|
Clene Inc.
|
654 Thousand USD
|
52.599%
|
Indaptus Therapeutics, Inc.
|
- USD
|
-Infinity%
|
BeyondSpring Inc.
|
1.75 Million USD
|
82.296%
|
Synlogic, Inc.
|
3.37 Million USD
|
90.804%
|
Allarity Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Phio Pharmaceuticals Corp.
|
- USD
|
-Infinity%
|
Peak Bio, Inc.
|
367.87 Thousand USD
|
15.733%
|
Werewolf Therapeutics, Inc.
|
19.94 Million USD
|
98.446%
|
Krystal Biotech, Inc.
|
50.69 Million USD
|
99.389%
|
Karyopharm Therapeutics Inc.
|
146.03 Million USD
|
99.788%
|
SpringWorks Therapeutics, Inc.
|
5.44 Million USD
|
94.309%
|
Lipella Pharmaceuticals Inc.
|
449.61 Thousand USD
|
31.052%
|
MannKind Corporation
|
198.96 Million USD
|
99.844%
|
Ikena Oncology, Inc.
|
9.16 Million USD
|
96.616%
|
Cyclerion Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Gyre Therapeutics, Inc.
|
113.45 Million USD
|
99.727%
|
Gossamer Bio, Inc.
|
- USD
|
-Infinity%
|
CohBar, Inc.
|
- USD
|
-Infinity%
|
Cognition Therapeutics, Inc.
|
- USD
|
-Infinity%
|
NRx Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Legend Biotech Corporation
|
285.14 Million USD
|
99.891%
|
Mural Oncology plc
|
- USD
|
-Infinity%
|
Biora Therapeutics, Inc.
|
4000.00 USD
|
-7650.0%
|
PaxMedica, Inc. Common Stock
|
- USD
|
-Infinity%
|
Disc Medicine, Inc.
|
- USD
|
-Infinity%
|
Champions Oncology, Inc.
|
50.15 Million USD
|
99.382%
|
REGENXBIO Inc.
|
90.24 Million USD
|
99.656%
|
Ensysce Biosciences, Inc.
|
2.23 Million USD
|
86.102%
|
Anavex Life Sciences Corp.
|
- USD
|
-Infinity%
|
Cellectar Biosciences, Inc.
|
- USD
|
-Infinity%
|
Edgewise Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Vaxart, Inc.
|
7.37 Million USD
|
95.799%
|
PharmaCyte Biotech, Inc.
|
- USD
|
-Infinity%
|
Aldeyra Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Cellectis S.A.
|
755 Thousand USD
|
58.94%
|
Longeveron Inc.
|
709 Thousand USD
|
56.276%
|
Repare Therapeutics Inc.
|
51.13 Million USD
|
99.394%
|
Sarepta Therapeutics, Inc.
|
1.24 Billion USD
|
99.975%
|
Inozyme Pharma, Inc.
|
- USD
|
-Infinity%
|
Revolution Medicines, Inc.
|
11.58 Million USD
|
97.323%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
Third Harmonic Bio, Inc.
|
- USD
|
-Infinity%
|
ArriVent BioPharma, Inc. Common Stock
|
- USD
|
-Infinity%
|
AN2 Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anixa Biosciences, Inc.
|
210 Thousand USD
|
-47.619%
|
Vertex Pharmaceuticals Incorporated
|
9.86 Billion USD
|
99.997%
|
Denali Therapeutics Inc.
|
330.53 Million USD
|
99.906%
|
Revelation Biosciences, Inc.
|
- USD
|
-Infinity%
|
Veru Inc.
|
16.29 Million USD
|
98.098%
|
Corvus Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Cingulate Inc.
|
- USD
|
-Infinity%
|
Passage Bio, Inc.
|
- USD
|
-Infinity%
|
Context Therapeutics Inc.
|
- USD
|
-Infinity%
|
Exicure, Inc.
|
- USD
|
-Infinity%
|
Day One Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Oramed Pharmaceuticals Inc.
|
2.7 Million USD
|
88.531%
|
Scinai Immunotherapeutics Ltd.
|
- USD
|
-Infinity%
|
Rhythm Pharmaceuticals, Inc.
|
77.42 Million USD
|
99.6%
|
Nuvalent, Inc.
|
- USD
|
-Infinity%
|
ABVC BioPharma, Inc.
|
152.43 Thousand USD
|
-103.372%
|
Carisma Therapeutics, Inc.
|
14.91 Million USD
|
97.922%
|
Unicycive Therapeutics, Inc.
|
675 Thousand USD
|
54.074%
|
OmniAb, Inc.
|
34.16 Million USD
|
99.093%
|
Anew Medical, Inc.
|
- USD
|
-Infinity%
|
Fennec Pharmaceuticals Inc.
|
21.25 Million USD
|
98.541%
|
Lipocine Inc.
|
-2.85 Million USD
|
110.874%
|
Lexeo Therapeutics, Inc. Common Stock
|
- USD
|
-Infinity%
|
Nautilus Biotechnology, Inc.
|
- USD
|
-Infinity%
|
SAB Biotherapeutics, Inc.
|
2.23 Million USD
|
86.154%
|
G1 Therapeutics, Inc.
|
82.51 Million USD
|
99.624%
|
Bellerophon Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Sage Therapeutics, Inc.
|
86.45 Million USD
|
99.641%
|
Ocugen, Inc.
|
6.03 Million USD
|
94.864%
|
Mind Medicine (MindMed) Inc.
|
- USD
|
-Infinity%
|
Q32 Bio Inc.
|
1.15 Million USD
|
73.183%
|
Brainstorm Cell Therapeutics Inc.
|
- USD
|
-Infinity%
|
Alumis Inc. Common Stock
|
- USD
|
-Infinity%
|
Equillium, Inc.
|
36.08 Million USD
|
99.141%
|
Kyverna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Coya Therapeutics, Inc.
|
6 Million USD
|
94.835%
|
CNS Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Galera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Evelo Biosciences, Inc.
|
- USD
|
-Infinity%
|
Comera Life Sciences Holdings, Inc.
|
633.1 Thousand USD
|
51.035%
|
Dominari Holdings Inc.
|
2.03 Million USD
|
84.796%
|
Edesa Biotech, Inc.
|
- USD
|
-Infinity%
|
vTv Therapeutics Inc.
|
- USD
|
-Infinity%
|
Bio-Techne Corporation
|
1.15 Billion USD
|
99.973%
|
Agios Pharmaceuticals, Inc.
|
26.82 Million USD
|
98.844%
|
Harmony Biosciences Holdings, Inc.
|
582.02 Million USD
|
99.947%
|
Prelude Therapeutics Incorporated
|
- USD
|
-Infinity%
|
Candel Therapeutics, Inc.
|
- USD
|
-Infinity%
|
iTeos Therapeutics, Inc.
|
12.59 Million USD
|
97.539%
|
Nkarta, Inc.
|
- USD
|
-Infinity%
|
BioCardia, Inc.
|
477 Thousand USD
|
35.01%
|
Iterum Therapeutics plc
|
- USD
|
-Infinity%
|